Boston Scientific (BSX) Reports In-Line Q1 EPS
Get Alerts BSX Hot Sheet
Price: $72.91 --0%
Revenue Growth %: +13.7%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +13.7%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.
Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue of $7.225-7.375 billion, versus prior guidance of $7.30-7.5 billion and the consensus of $7.43 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $86 at Truist Securities
- Amalgamated Bank (AMAL) Tops Q1 EPS by 15c
- Applied Industrial Technologies (AIT) Tops Q3 EPS by 8c; Updates outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!